• Removals due to concomitant disease not allowing the animal to stay on study (e.g. other treatments needed not compliant with protocol).
• Animal's death.
• Animal owner's refusal to continue study participation.
• Administration of a non-approved concurrent therapy, which may affect the integrity of the study data.
• 
S4: Concomitant Treatments
• lithium bromide (epilepsy)
• immunotherapy (atopy)
• tramadol (pain)
• opical fusidic acid/ betamethasone (moist dermatitis)
• pimobendan (cardiac insufficiency)
• phenobarbitone (epilepsy)
• topical diethanolamine fusidate/ framycetin sulfate/ nystatin/ prednisolone (otitis • externa)
• topical fusidic acid (conjunctivitis)
